Department of Urology, Spital Thurgau AG, Kantonspital Frauenfeld, Frauenfeld, Switzerland; Department of Urology, Stellenbosch University, Western Cape, South Africa; Hannover Medical School, Hannover, Germany.
Eur Urol Focus. 2022 Mar;8(2):365-367. doi: 10.1016/j.euf.2022.03.020. Epub 2022 Apr 5.
In 2022, endoscopic enucleation of the prostate (EEP) is the treatment of choice for benign prostatic obstruction (BPO) for glands >80 ml and is a valid alternative for patients with bleeding disorders. Unlike robot-assisted radical prostatectomy, EEP has no additional access-related trauma and can be performed using the same instruments as for bipolar enucleoresection. With favorable costs, EEP can serve as a global solution for BPO treatment.
2022 年，对于前列腺体积>80ml 的良性前列腺梗阻（BPO）患者，内镜前列腺切除术（EEP）是首选治疗方法，也是出血性疾病患者的有效替代治疗方法。与机器人辅助根治性前列腺切除术不同，EEP 没有额外的与通道相关的创伤，并且可以使用与双极前列腺切除术相同的器械进行操作。EEP 具有良好的成本效益，可以作为治疗 BPO 的全球解决方案。
